Target intelligence / Profile preview

Folate-dependent metabolic process

Molecular classification
Other (metabolic pathway)
01

Overview

"Folate-dependent metabolic processes" refer collectively to a network of biochemical reactions that require folates as essential cofactors. These processes are central to one-carbon metabolism, which involves transferring single carbon units necessary for synthesizing nucleotides (for DNA/RNA), certain amino acids, and S‐adenosylmethionine—the universal methyl donor used in numerous biological methylation reactions. Key enzymes include methionine synthase, thymidylate synthase, dihydrofolate reductase, serine hydroxymethyltransferases, among others. Disruption at any point can lead to clinical consequences such as megaloblastic anemia or increased risk for cancer due to aberrant DNA synthesis/methylation. The term "Folate-dependent metabolic processes" describes a pathway, not a single molecular target; thus it is not considered a canonical therapeutic target but rather encompasses several druggable proteins within its network.

Other names
Folate metabolismOne-carbon metabolismFolate-mediated one-carbon metabolismFolate pathway
02

Mechanism of action

Mechanisms relate to inhibition of key enzymes in the folate pathway. Inhibition of dihydrofolate reductase blocks regeneration of tetrahydrofolic acid, halting DNA synthesis. Inhibition of thymidylate synthase prevents dTMP formation for DNA replication. Antifolates compete with natural folates for enzyme binding or cellular uptake.

03

Biological functions

Nucleotide synthesis (DNA and RNA synthesis)Amino acid metabolismMethylation reactions, including DNA methylationCellular redox balance and antioxidant defense
04

Disease associations

Cancer (altered folate metabolism is linked to cancer development and treatment resistance)Cardiovascular disease (via homocysteine regulation)Neurodevelopmental disorders, including neural tube defectsMegaloblastic anemia (due to impaired DNA synthesis)
05

Safety considerations

Myelosuppression from antifolate drugs due to impaired nucleotide synthesis in rapidly dividing cells.Risk of neural tube defects with inadequate maternal folic acid intake during pregnancy.
06

Interacting drugs

Methotrexate

2 more in the full profile.

07

Biomarkers

Homocysteine levels (marker for functional folate status and cardiovascular risk)MTHFR gene polymorphisms affecting methylation capacity

Beyond the preview

Go deeper on Folate-dependent metabolic process.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Folate-dependent metabolic process.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call